Using mitochondrial sirtuins as drug targets: disease implications and available compounds
Crossref DOI link: https://doi.org/10.1007/s00018-016-2180-7
Published Online: 2016-03-23
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gertz, Melanie
Steegborn, Clemens
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (DE) (STE1701/5)
Deutsche Forschungsgemeinschaft (STE1701/15)
Oberfrankenstiftung (na)
Alzheimer Forschungsinitiative (DE) (na)
Text and Data Mining valid from 2016-03-23